EIRION THERAPEUTICS INC has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are NONA INTERNAT LTD DR, LICHTWER PHARMA AG and ANTERIOS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Australia | 3 | |
#3 | Canada | 3 | |
#4 | Brazil | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Edelson Jonathan | 15 |
#2 | Jonathan Edelson | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020231983A1 | Delaying peak effect and/or extending duration of response | |
WO2020117564A1 | Improved delivery of large agents | |
AU2019338459A1 | Plasminogen activator inhibitor 1 (PAI-1) inhibitors and uses therefor | |
CA3112549A1 | Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors | |
MX2019005833A | Transdermal delivery of large agents. |